MORPHINE-3-GLUCURONIDE - SILENT REGULATOR OF MORPHINE ACTIONS

被引:43
作者
LIPKOWSKI, AW
CARR, DB
LANGLADE, A
OSGOOD, PF
SZYFELBEIN, SK
机构
[1] HARVARD UNIV, MASSACHUSETTS GEN HOSP,SCH MED,MGH PAIN CTR, ANALGES PEPTIDE RES UNIT, BOSTON, MA 02114 USA
[2] HARVARD UNIV, MASSACHUSETTS GEN HOSP,SCH MED,MGH PAIN CTR, DEPT MED,ANALGES PEPTIDE RES UNIT, BOSTON, MA 02114 USA
[3] POLISH ACAD SCI, MED RES CTR, WARSAW, POLAND
[4] HOP LARIBOISIERE, CTR TRAITEMENT DOULEUR, F-75475 PARIS, FRANCE
关键词
MORPHINE-3-GLUCURONIDE; OPIOID; ANALGESIA; MORPHINE;
D O I
10.1016/0024-3205(94)90106-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To assess whether stoichiometric manipulation of morphine (M) metabolism can enhance analgesia or slow the development of M tolerance we co-administered M-3- glucuronide (M3G) during single or repeated doses of morphine in rats. Although M3G itself lacked analgesic activity, co-injection of M3G with M increased and prolonged analgesia beyond that seen with M. In addition, diminution of the acute analgesic effect of M after 3 once-daily doses of M did not occur after daily co-injection of M3G and M. Thus the traditional view that tolerance to the effects of M is due solely to effects mediated through opioid receptors must be broadened to include the contributions of enzyme induction or stoichiometric equilibration of M3G in this process.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 20 条
  • [1] CARR DB, 1992, CLIN PRACTICE GUIDEL
  • [2] CARR DB, 1990, OPIOIDS ANESTHESIA 2, P3
  • [3] THE ENANTIOSELECTIVE GLUCURONIDATION OF MORPHINE IN RATS AND HUMANS - EVIDENCE FOR THE INVOLVEMENT OF MORE THAN ONE UDP-GLUCURONOSYLTRANSFERASE ISOENZYME
    COUGHTRIE, MWH
    ASK, B
    RANE, A
    BURCHELL, B
    HUME, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) : 3273 - 3280
  • [4] FUJIMOTO JM, 1969, J PHARMACOL EXP THER, V165, P45
  • [5] ANALYSIS OF MORPHINE AND ITS MAJOR METABOLITES BY DIFFERENTIAL RADIOIMMUNOASSAY
    HAND, CW
    MOORE, RA
    MCQUAY, HJ
    ALLEN, MC
    SEAR, JW
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1987, 24 : 153 - 160
  • [6] BLOCKADE OF TOLERANCE TO MORPHINE BUT NOT TO KAPPA-OPIOIDS BY A NITRIC-OXIDE SYNTHASE INHIBITOR
    KOLESNIKOV, YA
    PICK, CG
    CISZEWSKA, G
    PASTERNAK, GW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) : 5162 - 5166
  • [7] SEPARATION OF MORPHINE ANALGESIA FROM PHYSICAL-DEPENDENCE
    LING, GSF
    MACLEOD, JM
    LEE, S
    LOCKHART, SH
    PASTERNAK, GW
    [J]. SCIENCE, 1984, 226 (4673) : 462 - 464
  • [8] BIVALENT OPIOID PEPTIDE ANALOGS WITH REDUCED DISTANCES BETWEEN PHARMACOPHORES
    LIPKOWSKI, AW
    KONECKA, AM
    SROCZYNSKA, I
    PRZEWLOCKI, R
    STALA, L
    TAM, SW
    [J]. LIFE SCIENCES, 1987, 40 (23) : 2283 - 2288
  • [9] ORAL MORPHINE IN CANCER PAIN - INFLUENCES ON MORPHINE AND METABOLITE CONCENTRATION
    MCQUAY, HJ
    CARROLL, D
    FAURA, CC
    GAVAGHAN, DJ
    HAND, CW
    MOORE, RA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) : 236 - 244
  • [10] PHARMACOLOGICAL EFFECTS OF DRUG CONJUGATES - IS MORPHINE 6-GLUCURONIDE AN EXCEPTION
    MULDER, GJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (08) : 302 - 304